Firefly to offer NeuroSigma’s non-drug ADHD device to clinicians

Firefly is now offering NeuroSigma's non-drug ADHD treatment device to clinicians. The device provides an alternative to medication for managing ADHD symptoms. This expansion aims to increase access to non-pharmacological ADHD treatments.

Read at Medical Device Network

All articles from 29 September 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.